United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - methotrexate - oral tablet - 10mg

Ireland - English - HPRA (Health Products Regulatory Authority)

rosemont pharmaceuticals ltd - methotrexate disodium - oral solution - 2 mg/ml - methotrexate - antineoplastic and immunomodulating agents, antimetabolites, folic acid analogues - it is indicated in the following oncological indications: the maintenance treatment of acute lymphocytic leukaemia (all) in children and adults; the treatment of malignant trophoblastic tumours and for the treatment of severe active rheumatoid arthritis in adults and the treatment of severe forms of psoriasis vulgaris including chronic plaque psoriasis, erythrodermic psoriasis, psoriatic arthritis and pustular psoriasis which are not responsive to other conventional therapies such as phototherapy, puva and retinoids.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - methotrexate - oral tablet - 2.5mg

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

waverley pharma europe ltd. - pemetrexed disodium - eq. pemetrexed 100 mg - powder for concentrate for solution for infusion - 100 mg - pemetrexed disodium - pemetrexed

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

waverley pharma europe ltd. - pemetrexed disodium - eq. pemetrexed 500 mg - powder for concentrate for solution for infusion - 500 mg - pemetrexed disodium - pemetrexed

New Zealand - English - Medsafe (Medicines Safety Authority)

rex medical ltd - methotrexate 10mg - tablet - 10 mg - active: methotrexate 10mg excipient: calcium hydrogen phosphate lactose monohydrate magnesium stearate microcrystalline cellulose purified talc sodium starch glycolate - antineoplastic chemotherapy treatment of breast cancer, gestational choriocarcinoma, and in patients with chorioadenoma destruens and hydatidiform mole. palliation of acute and subacute lymphocytic leukaemia. greatest effect has been observed in palliation of acute lymphoblastic (stem cell) leukaemias. in combination with corticosteroids, methotrexate may be used for induction of remission. the drug is now most commonly used for the maintenance of induced remissions. methotrexate is also effective in the treatment of the advanced states (iii and iv, peters staging system) of lymphosarcoma, particularly in children and in advanced cases of mycosis fungoides.

New Zealand - English - Medsafe (Medicines Safety Authority)

rex medical ltd - methotrexate 2.5mg - tablet - 2.5 mg - active: methotrexate 2.5mg excipient: calcium hydrogen phosphate lactose monohydrate magnesium stearate microcrystalline cellulose purified talc sodium starch glycolate - antineoplastic chemotherapy treatment of breast cancer, gestational choriocarcinoma, and in patients with chorioadenoma destruens and hydatidiform mole. palliation of acute and subacute lymphocytic leukaemia. greatest effect has been observed in palliation of acute lymphoblastic (stem cell) leukaemias. in combination with corticosteroids, methotrexate may be used for induction of remission. the drug is now most commonly used for the maintenance of induced remissions. methotrexate is also effective in the treatment of the advanced states (iii and iv, peters staging system) of lymphosarcoma, particularly in children and in advanced cases of mycosis fungoides.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - pemetrexed disodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - pemetrexed disodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - pemetrexed disodium -